Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL at 6: Banning cell phones in the classroom. Why schools and parents are debating whether your students' phones belong at school.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tarsus Pharmaceuticals Inc
(NQ:
TARS
)
26.56
-0.10 (-0.38%)
Streaming Delayed Price
Updated: 2:19 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Tarsus Pharmaceuticals Inc
< Previous
1
2
Next >
Tarsus to Present at the Jefferies Global Healthcare Conference
June 05, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Reports First Quarter 2023 Financial Results and Recent Business Achievements
May 09, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Launches “Don’t Freak Out. Get Checked Out.” Campaign During Healthy Vision Month to Encourage Patients with Demodex Blepharitis to Visit Eye Care Providers
May 08, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus to Participate at the Bank of America 2023 Healthcare Conference
May 03, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Appoints Jeff Farrow as Chief Financial Officer and Chief Strategy Officer
April 24, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Reports Full-Year 2022 Financial Results and Recent Business Achievements
March 13, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus to Present at Upcoming Investor Conferences
March 02, 2023
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Added to NASDAQ Biotechnology Index
December 16, 2022
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Announces Positive Topline Data from Phase 1b Callisto Trial and Initiates Phase 2a Carpo Human Tick Kill Trial Evaluating TP-05, A Novel, Oral Therapeutic for the Prevention of Lyme Disease
December 15, 2022
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Reports Third Quarter 2022 Financial Results and Recent Business Achievements
November 09, 2022
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus to Present Additional Saturn-2 Pivotal Phase 3 Trial Data at the American Academy of Optometry 2022 Annual Meeting
October 25, 2022
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Announces Transition Plans for Board of Directors
October 11, 2022
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Appoints Scott Morrison as Board Member and Audit Committee Chair
October 06, 2022
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
Tarsus Launches “Look at the Lids” Campaign to Encourage Eye Care Professionals to Identify and Diagnose Demodex Blepharitis
September 29, 2022
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.